Biolase SG&A Expense (Quarterly) Insights

Biolase Inc (BIOL)

0.159 0.00 (0.00%) USD | NASDAQ | May 17, 16:00

0.1579 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1992. Upgrade now.

Date	Value
March 31, 2024	6.579M
December 31, 2023	6.948M
September 30, 2023	6.081M
June 30, 2023	8.546M
March 31, 2023	7.081M
December 31, 2022	9.935M
September 30, 2022	8.117M
June 30, 2022	8.543M
March 31, 2022	7.391M
December 31, 2021	7.669M
September 30, 2021	5.93M
June 30, 2021	6.09M
March 31, 2021	6.911M
December 31, 2020	6.093M
September 30, 2020	4.978M
June 30, 2020	4.23M
March 31, 2020	5.714M
December 31, 2019	6.365M
September 30, 2019	6.725M
June 30, 2019	5.783M
March 31, 2019	6.272M
December 31, 2018	8.164M
September 30, 2018	7.174M
June 30, 2018	7.626M
March 31, 2018	6.928M

Date	Value
December 31, 2017	6.441M
September 30, 2017	6.015M
June 30, 2017	7.374M
March 31, 2017	6.60M
December 31, 2016	7.219M
September 30, 2016	7.038M
June 30, 2016	7.143M
March 31, 2016	6.071M
December 31, 2015	6.053M
September 30, 2015	6.899M
June 30, 2015	8.659M
March 31, 2015	7.341M
December 31, 2014	7.476M
September 30, 2014	7.336M
June 30, 2014	8.879M
March 31, 2014	7.538M
December 31, 2013	7.20M
September 30, 2013	6.624M
June 30, 2013	6.736M
March 31, 2013	7.499M
December 31, 2012	6.671M
September 30, 2012	5.474M
June 30, 2012	5.941M
March 31, 2012	6.239M
December 31, 2011	6.418M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.23M

Minimum

Jun 2020

9.935M

Maximum

Dec 2022

6.785M

Average

6.652M

Median

SG&A Expense (Quarterly) Benchmarks